Finasteride vs Nivolumab

Finasteride vs Nivolumab: Overview

This comparison examines the pharmacological differences between Finasteride and Nivolumab.

Mechanism of Action

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Finasteride — 5-6 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Finasteride — C23H36N2O2.

Molecular Weight: Finasteride — 372.5490 g/mol.

Type: Finasteride — Small molecule; Nivolumab — Antibody.